SCHEMBL6974967

SCHEMBL6974967

NC(=O)c1cccc(CN2CC[C@H](NC(=O)[C@@H]3CCCCN3c3nc4ccccc4o3)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.45
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 1/20 0.44
ROCK2 O75116 1/20 0.43
DRD2 P14416 3/20 0.42
DRD4 P21917 3/20 0.42
ACKR3 P25106 4/20 0.41
CCR4 P51679 1/20 0.41
KDM1A O60341 1/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MCHR1 Q99705 1/20 0.40
HTR2A P28223 1/20 0.40
FAAH O00519 1/20 0.39
MGLL Q99685 1/20 0.39
ELANE P08246 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968264 0.90 OPRK1 (0.56) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6978779 0.90 OPRK1 (0.56) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6975047 0.86 OPRK1 (0.48) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6974472 0.85 LMNA (0.52) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6967773 0.85 CXCR4 (0.47) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL7084048 0.85 LMNA (0.46) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6966984 0.84 LMNA (0.50) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6971418 0.84 LMNA (0.54) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6975288 0.83 LMNA (0.48) OPRK1LMNASMN1; SMN2TSHRHTT
SCHEMBL6972482 0.82 OPRK1 (0.44) OPRK1DRD2DRD4CCR4MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP claimed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US claimed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed
EP-1100797-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES Pfizer Limited (GB) 2001-05-23 EP disclosed
WO-2000005232-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LIMITED (GB) 2000-02-03 WO disclosed